Hypofractionated radiotherapy for patients with carcinoma of the bladder

Clinical Oncology

Volumn 11, Issue 5, 1999, Pages 330-333

  Jose, C C ^a   Price, A ^a   Norman, A ^a   Jay, G ^a   Huddart, R ^a   Dearnaley, D P ^a   Horwich, A ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Bladder cancer; Hypofractionation; Radiotherapy

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; BLADDER CAPACITY; BLADDER DISEASE; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CYSTOSCOPY; FEMALE; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; URINARY TRACT OBSTRUCTION;

EID: 0032727504     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.1999.9075     Document Type: Article

References (17)

1. Heston JF, Kelly JB, Meigs JW, et al. 65 years of cancer incidence in Connecticut 1935-1979. NCI Monogr 1990;70:415.
2. Duncan W, Williams J, Kerr GR, et al. An analysis of the radiation related morbidity observed in a randomised trial of neutron therapy for bladder cancer. Int J Radiat Oncol Biol Phys 1986; 12:2085-92.
3. Collins CD, Lloyd-Davies RW, Swan AV. Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clin Oncol 1991;3:127-32.
4. Salminen E. Unconventional fractionation for palliative radiotherapy of urinary bladder cancer: a retrospective review of 94 patients. Acta Oncol 1992;31:449-54.
5. Rostom AY, Tahir S, Gershuny AR, et al. Once weekly irradiation for carcinoma of the bladder. Int J Radiat Oncol Biol Phys 1996;35:289-92.
6. UICC Internationale contre le Cancer. TNM classification of malignant tumours. Springer-Verlag: International Union Against Cancer, 1987.
7. Perez CA, Brady LW. Overview. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Philadelphia, PA: Lippincott, 1992:1-63.
8. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. 2: Analysis and examples. Br J Cancer 1977;35:1-39.
9. Fowler JF. Review: total doses in fractionated radiotherapy: implications of new radiobiological data. Int J Radiat Biol Relat Stud Phys Chem Med 1984;46:103-20.
10. Fowler JF. The linear-quadratic formula and progression in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
11. Joiner MJ. The linear-quadratic approach to fractionation. In: Steel GG, editor. Basic clinical radiobiology for radiation oncologists. London: Edward Arnold, 1993:55-64.
12. Singh K. Two regimes with the same TDF but differing morbidity used in the treatment of Stage III carcinoma of the cervix. Br J Radiol 1978;51:357-62.
13. Fletcher GH. Hypofractionation: lessons from complications. Radiother Oncol 1991;20:10-5.
14. Slawson RG, Salazar OM, Poussin Rosillo H, et al. Oncea-week vs conventional daily radiation treatment for lung cancer: final report. Int J Radiat Oncol Biol Phys 1988;15:61-8.
15. Baillet F, Housset M, Maylin C, et al. The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomised study of 230 patients. Int J Radiat Oncol Biol Phys 1990;19:1131-3.
16. Quilty PM, Duncan W. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys 1986;12:853-60.
17. Bessell EM, Taylor J, Moloney AJ, et al. Regression of transitional cell carcinoma of the bladder with radiotherapy: progression-free control in the bladder at 5 years. Radiother Oncol 1993;29:344-6.